Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Durable Leukemia and HIV Remission without Antiviral Therapy Following an Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) Using a Donor with CCR5-Δ32/Δ32 Homozygosity for an Acute Myeloid Leukemia (AML) Patient

Ahmed Aribi, Lihua E Budde, Joseph C. Alvarnas, Eileen P. Smith, Amandeep Salhotra, Monzr M. Al Malki, Wen Yi-Ping, John Zaia, Guido Marcucci, Jana Dickter, Stephen J Forman

Blood (2022) 140 (Supplement 1): 7597–7598.

https://doi.org/10.1182/blood-2022-169223

Published: 2022

Journal Articles

Sinusoidal Obstruction Syndrome in Adult Patients with B-Cell Acute Lymphoblastic Leukemia Treated with Inotuzumab Prior to Hematopoietic Stem Cell Transplantation

Blood (2022) 140 (Supplement 1): 10449–10450.

https://doi.org/10.1182/blood-2022-165839

Published: 2022

Journal Articles

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL

Blood (2022) 140 (Supplement 1): 8985–8986.

https://doi.org/10.1182/blood-2022-170279

Published: 2022

Journal Articles

Long Term Outcomes of Patients with Chronic Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation in the Era of Oral Tyrosine Kinase Inhibitors

Blood (2022) 140 (Supplement 1): 12945–12946.

https://doi.org/10.1182/blood-2022-170009

Published: 2022

Journal Articles

Evaluation of 5-Day Vs. 10-Day Decitabine in Combination with Venetoclax in Newly Diagnosed AML Patients Ineligible for Induction Chemotherapy

Blood (2022) 140 (Supplement 1): 9039–9040.

https://doi.org/10.1182/blood-2022-170867

Published: 2022

Journal Articles

Novel Salvage Therapies Are Highly Effective in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) with Philadelphia (Ph)-like Fusions

Blood (2022) 140 (Supplement 1): 6020–6022.

https://doi.org/10.1182/blood-2022-158288

Published: 2022

Journal Articles

Outcomes of Venetoclax and Hypomethylating Agents (HMA) in Adult Patients with KMT2A-Rearranged Leukemias

Brian Ball, Shukaib Arslan, Paul Koller, Joyce Murata-Collins, Michelle Afkhami, Raju Pillai, Karl Gaal, Amandeep Salhotra, Monzr M. Al Malki, Ahmed Aribi, Haris Ali, Salman Otoukesh, Idoroenyi Amanam, Ryotaro Nakamura, Eileen P. Smith, Forrest Stewart, Guido Marcucci, Vinod A. Pullarkat, Ibrahim Aldoss

Blood (2021) 138 (Supplement 1): 3430.

https://doi.org/10.1182/blood-2021-148670

Published: 2021

Journal Articles

The Impact of Letermovir (LTV) Prophylaxis on Early Cytomegalovirus Infection (CMVi) and Outcomes in the Adult Allogeneic Hematopoietic Cell Transplantation (alloHCT) Recipients with High-Risk Donor Type

Sanjeet S Dadwal, Dongyun Yang, Guido Marcucci, Sally Mokhtari, Bernard Tegtmeier, Joycelynne Palmer, Eileen P. Smith, Randy Taplitz, Andrew S. Artz, Peter T. Curtin, Ricardo Spielberger, Amandeep Salhotra, Anthony S. Stein, Stephen J Forman, Monzr M. Al Malki, Ryotaro Nakamura

Blood (2021) 138 (Supplement 1): 1776.

https://doi.org/10.1182/blood-2021-153784

Published: 2021

Journal Articles

Real World Evaluation of Deviation Outcomes in an Immune Effector Cell Quality Program

Geoffrey Shouse, DO, PhD, Sylvia O Dulan, RN, Jamie Wagner, BS, Michelle Mott, RN, Alex Ly, Donna Ujiiye, Mary C. Clark, PhD, Kathie Viers, RN, Stephen J. Forman, MD, Eileen P. Smith, MD, David S Snyder, MD, Lihua E Budde, MD PhD

Blood (2020) 136 (Supplement 1): 10.

https://doi.org/10.1182/blood-2020-143412

Published: 2020

Journal Articles

Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients with Mature T-Cell NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen"

Jasmine Zain, MD, Jennifer Simpson, Joycelynne Palmer, PhD, Jeffrey Wong, MD, Savita Dandapani, MD PhD, David Colcher, PhD, Nicole Karras, MD, Alex F. Herrera, MD, Amandeep Salhotra, MD, Auayporn P. Nademanee, MDBS, Ryotaro Nakamura, MD, Eileen P. Smith, MD, Ni-Chun Tsai, MS, David Yamauchi, MD, Erasmus Kofi Poku, PharmD, Van Eric Biglang-awa, PharmD, John E. Shively, PhD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-141114

Published: 2020

Journal Articles

Hemorrhagic Cystitis in Patients Undergoing Allogeneic Hematopoietic Cell Transplant with Post Transplant Cyclophosphamide As GvHD Prophylaxis

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-139993

Published: 2020

Journal Articles

Healthcare Resource Utilization in Transplant Patients Who Are at a Higher-Risk to Develop Cytomegalovirus Infection during Their Primary Transplant-Related Hospitalization

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-143452

Published: 2020

Journal Articles

Updated Analysis: Novel Machine-Learning-Based Sepsis Prediction Model for Patients Undergoing Hematopoietic Stem Cell Transplantation (Early Sepsis Prediction/Identification for Transplant Recipients: ESPRIT)

Zahra Eftekhari, MS, Sally Mokhtari, PhD, Tushondra Thomas, MSN, MBA, PHN, RN-BC, Dongyun Yang, PhD, Liana Nikolaenko, MD, Deron Johnson, PharmD, Jana Dickter, MD, Justine Abella Ross, PharmD, Bernard Tegtmeier, PhD D(ABMM), CIC, Eileen P. Smith, MD, Monzr M. Al Malki, MD, Ricardo Spielberger, MD, Anna B Pawlowska, MD, Argelia Sandoval, MD, John Zaia, MD, Stephen J Forman, MD, Janet Munu, BSc, MBA, RN, Sanjeet Dadwal, MD, Ryotaro Nakamura, MD

Blood (2019) 134 (Supplement_1): 4477.

https://doi.org/10.1182/blood-2019-130926

Published: 2019

Journal Articles

Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic CELL Transplantation (AHCT) in Patients with Mature T-CELL NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen"

Jasmine Zain, MD, Jennifer Simpson, Joycelynne Palmer, Jeffrey Wong, MD, Savita Dandapani, MD PhD, David Colcher, PhD, Nicole Karras, MD, Alex F. Herrera, MD, Amandeep Salhotra, MD, Auayporn P. Nademanee, MDBS, Ryotaro Nakamura, MD, Eileen P. Smith, MD, Ni-Chun Tsai, David Yamauchi, MD, Kofi Poku, PharmD, Van Biglang-awa, PharmD, John E. Shively

Blood (2018) 132 (Supplement 1): 611.

https://doi.org/10.1182/blood-2018-99-116907

Published: 2018

Journal Articles

Melphalan-Based Regimen Is a Safe and Effective Conditioning Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Older Adults (≥70 years) with Hematological Malignancies

Blood (2017) 130 (Supplement 1): 1995.

https://doi.org/10.1182/blood.V130.Suppl_1.1995.1995

Published: 2017

Journal Articles

Understanding Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia in a Real-World Setting

Julie A. Wolfson, MD, Joshua Richman, MD PhD, Can-Lan Sun, PhD, Wendy Landier, PhD CRNP, Karen Leung, BA, Eileen P. Smith, MD, Margaret R. O'Donnell, MD, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 352.

https://doi.org/10.1182/blood.V130.Suppl_1.352.352

Published: 2017

Journal Articles

Dissecting the Outcome Difference Between Children and Adolescents and Young Adults (AYAs) with Acute Lymphoblastic Leukemia (ALL)

Julie A. Wolfson, MD, Joshua Richman, MD PhD, Canlan Sun, PhD, Wendy Landier, PhD CRNP, Karen Leung, BA, Eileen P. Smith, MD, Margaret O'Donnell, MD, Smita Bhatia, MD MPH

Blood (2016) 128 (22): 1601.

https://doi.org/10.1182/blood.V128.22.1601.1601

Published: 2016

Journal Articles

A Multivariate Clinical and Economic Model for Predicting Risk-Based Costs of Care for Acute Leukemia (AL) Patients (Pts) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Joseph C. Alvarnas, MD, Guido Marcucci, MD, Ann Vanderplas, MS, Eileen P. Smith, MD, Joyce L. Murata-Collins, PhD, Alexandra M. Levine, MD, Joyce Niland, MD, Joycelynne Palmer, PhD, Tsai Ni-Chun, Rebecca Ottesen, Michael Rabin, Zara Dzagikian, Shery Azimi, Joseph Rosenthal, MD MS, Harlan Levine, MD, Stephen J. Forman, MD

Blood (2016) 128 (22): 3547.

https://doi.org/10.1182/blood.V128.22.3547.3547

Published: 2016

Journal Articles

Combination of Dasatinib with Conventional Chemotherapy Is Associated with a High Response Rate in High Risk Acute Myeloid Leukemia (AML)

Blood (2015) 126 (23): 3743.

https://doi.org/10.1182/blood.V126.23.3743.3743

Published: 2015

Journal Articles

SWOG S0410/BMT CTN 0703: A Phase II Trial of Tandem Autologous Stem Cell Transplantation (AHCT) for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma (HL) (ClinicalTrials.gov Identifier: NCT00233987)

Eileen P. Smith, MD, Hongli Li, M.S., Jonathan W. Friedberg, MD, Louis Constine, MD, Lisa M. Rimsza, MD, Ginna G. Laport, MD, Leslie L. Popplewell, MD, David G Maloney, MDPhD, Michael Leblanc, PhD, Stephen J. Forman, MD, Richard I. Fisher, MD, Patrick J. Stiff, MD

Blood (2014) 124 (21): 676.

https://doi.org/10.1182/blood.V124.21.676.676

Published: 2014

NARROW

Durable Leukemia and HIV Remission without Antiviral Therapy Following an Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) Using a Donor with CCR5-Δ32/Δ32 Homozygosity for an Acute Myeloid Leukemia (AML) Patient

Sinusoidal Obstruction Syndrome in Adult Patients with B-Cell Acute Lymphoblastic Leukemia Treated with Inotuzumab Prior to Hematopoietic Stem Cell Transplantation

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL

Long Term Outcomes of Patients with Chronic Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation in the Era of Oral Tyrosine Kinase Inhibitors

Evaluation of 5-Day Vs. 10-Day Decitabine in Combination with Venetoclax in Newly Diagnosed AML Patients Ineligible for Induction Chemotherapy

Novel Salvage Therapies Are Highly Effective in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) with Philadelphia (Ph)-like Fusions

Outcomes of Venetoclax and Hypomethylating Agents (HMA) in Adult Patients with KMT2A-Rearranged Leukemias

The Impact of Letermovir (LTV) Prophylaxis on Early Cytomegalovirus Infection (CMVi) and Outcomes in the Adult Allogeneic Hematopoietic Cell Transplantation (alloHCT) Recipients with High-Risk Donor Type

Real World Evaluation of Deviation Outcomes in an Immune Effector Cell Quality Program

Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients with Mature T-Cell NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen"

Hemorrhagic Cystitis in Patients Undergoing Allogeneic Hematopoietic Cell Transplant with Post Transplant Cyclophosphamide As GvHD Prophylaxis

Healthcare Resource Utilization in Transplant Patients Who Are at a Higher-Risk to Develop Cytomegalovirus Infection during Their Primary Transplant-Related Hospitalization

Updated Analysis: Novel Machine-Learning-Based Sepsis Prediction Model for Patients Undergoing Hematopoietic Stem Cell Transplantation (Early Sepsis Prediction/Identification for Transplant Recipients: ESPRIT)

Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic CELL Transplantation (AHCT) in Patients with Mature T-CELL NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen"

Melphalan-Based Regimen Is a Safe and Effective Conditioning Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Older Adults (≥70 years) with Hematological Malignancies

Understanding Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia in a Real-World Setting

Dissecting the Outcome Difference Between Children and Adolescents and Young Adults (AYAs) with Acute Lymphoblastic Leukemia (ALL)

A Multivariate Clinical and Economic Model for Predicting Risk-Based Costs of Care for Acute Leukemia (AL) Patients (Pts) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Combination of Dasatinib with Conventional Chemotherapy Is Associated with a High Response Rate in High Risk Acute Myeloid Leukemia (AML)

SWOG S0410/BMT CTN 0703: A Phase II Trial of Tandem Autologous Stem Cell Transplantation (AHCT) for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma (HL) (ClinicalTrials.gov Identifier: NCT00233987)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only